+34 620 10 75 37info@nanbiosis.com

News

nanbiosis news

The Conferences in Nanotechnology of major reference at Spanish level.

Last November, 7th, the 10th AIN Conference on Industrial Applications of Nanotechnology, held in Zaragoza, brought together experts from research centres, universities and companies on the Industrial Applications of Nanotechnology. Among  them Jordi Reverter, Head of Knowledge and Technology Transfer of ICN2, (Institute housing  Unit 4 of NANBIOSIS) and Ricardo Ibarra, director of Institute of Nanoscience of Aragon (INA) which houses Unit 9 of NANBIOSIS) .

Joan Parra, director of the technology centre LEITAT  of  Catalonia, described the event as “Conferences of greater reference at Spanish level in Nanotechnology

During the meeting, their experience with nanotechnology was shown by the ICTS Elecmi and companies such as Grupo Antolín, Samca Group, BSH Electrodomésticos, Cepsa, Argenol Laboratories and Graphene Nanotech.

Dr. Jose L. Hueso (Unit 9 of NANBIOSIS) presented a recently patented nanocatalyst with great potential for its application in both biomedical and petrochemical fields.

The Conferences in Nanotechnology of major reference at Spanish level.
Read More

Award to the best oral presentation in the 2016 Spanish Society of Cardiology Meeting

The oral presentation entitled “NonInvasive Assessment of an engineered bioactive graft using impedance spectroscopy in a swine myocardial infarction”, presented in the 2016 Spanish Society of Cardiology Meeting, has been awarded.

The Heart Diseases Meeting, held in the town of Zaragoza last 27-29th October, was focused on sharing experiences, making contacts and updating some knowledge.

The event got together cardiologists, general practitioners, researchers, internists, epidemiologists, practitioner residents and nurses, offering more than 140 activities and nearly 1000 communications.

Carolina Gálvez-Montón, Ramón Bragós, Carolina Soler-Botija, Idoia Díaz-Güemes, Cristina Prat-Vidal, Verónica Crisóstomo, Francisco Miguel Sánchez-Margallo and Antoni Bayés-Genís (three of them JUMISC’semployees), were the authors awarded by the best oral presentation.

This is the result of the collaboration between the Germans Trias i Pujol Hospital, the Politécnica of Cataluña University, the Autónoma University of Barcelona and the Jesús Usón Minimally Invasive Surgery Centre (JUMISC).

More Information

Award to the best oral presentation in the 2016 Spanish Society of Cardiology Meeting
Read More

Forum and Partnering CIBER-BBN with l’Università degli Studi di Torino

Next November 8, 2016 will be held at the Residence for Researchers of CSIC in Barcelona a meeting between researchers from NANBIOSIS Units and other CIBER-BBN researchers with researchers from the University of Torino.

This event is organized by NANBIOSIS and partially funded by the Ministry of Economy and Competitiveness through PRONANBIOSIS SAF2015-69388-REDI Project for ICTS.

The event consists of a series of presentations by the assistant research groups and B2B partnership, with more than 60 pre-arranged individual meetings and the possibility of organising new meetings after listening the presentations.

The final object is to interact to seek collaborations and promoting joint projects.

Nanbiosis - Forum and Partnering CIBER-BBN with l’Università degli Studi di Torino
Read More

X Industrial Applications of Nanotechnology Days

On 7 and 8 November 2016, will take place in Zaragoza the X edition of the Industrial Applications of Nanotechnology Days.

This event is organized by the Institute of Nanoscience of Aragon (INA) – housing Unit 9 of NANBIOSIS- and the Catalan Institute of Nanoscience and Nanotechnology (ICN2), which houses Unit 4 of NANBIOSIS, in conjunction with the Leitat Technology Centre.

The event consists of  two days : The Nov.7th, in the Chamber of Commerce of Zaragoza: Presentation of new industrial applications in nanotechnology, in which companies will present their multiple industrial applications of nanotechnology and Nov. 8th in the Nanoscience institute of Aragon: Practical day on materials and surfacescCharacterización.

Program information and registration

 

X Industrial Applications of Nanotechnology Days
Read More

Spanish nanotechnology in the National Academy of Medicine of USA

Maria Jose Alonso, (faculty of pharmacy, University of Santiago de Compostela) is one of the nine new international members elected by the Academy of Medicine of the United States. The current number of international members is 146, being two of them Spanish researchers, working in Spain (the other Spanish member is Josep Dalmau, professor of neurology at the University of Barcelona.

Maria José Alonso occupies the ninth place in the international ranking Times Higher Education (Thomson Reuters), it has 19 patent families. Her lab has been a pioneer in Spain in the field of nanotechnology and has made significant advances in cancer vaccines.

Source: Diario Médico

Spanish nanotechnology in the National Academy of Medicine of USA
Read More

Water-in-water (W/W) emulsions

Jordi Esquena, Scientific Coordinator of Unit 12 of NANBIOSIS, has recently published an interesting review in the journal Current Opinion in Colloid & Interface Science, about W/W emulsions. Dr. Esquena describes the general background of research in the field and focuses on recent scientific advances and applications.

Water-in-water (W/W) emulsions are colloidal dispersions of an aqueous solution into another aqueous phase. Such dispersions can be formed in mixtures of at least two hydrophilic macromolecules, which are thermodynamically incompatible in solution, generating two immiscible aqueous phases. Highly stable water-in-water emulsions can be formulated using fully biocompatible and edible components, and consequently, these emulsions can be used in food and pharmaceutical formulations, among many other interesting applications.

More information

Water-in-water (W/W) emulsions
Read More

Congress Excellence 2016

The Spanish University with the highest number of scientifically distinguished research institutes is Universitat Autònoma de Barcelona with five Centres of Excellence “Severo Ochoa” and two Units of Excellence “María de Maeztu”.

ICMAB-CSIC, Research Institute housing unit 6 of NANBIOSIS and one of the five Severo Ochoa Centers of UAB organised the Congress Excellence 2016

More information

Congress Excellence 2016
Read More

#ImproCiencia: Science and theatre

Next November 15 from 19: 30h to 21h #ImproCiencia will repeat an initiative organized by the Center for Biomedical Research Network (CIBER) to raise awareness in a fun way what the CIBER and some of the research do in its various subject areas.

This year the presentations will be performed mostly by scientist women to highlight their essential role in nowadays research.

Free admission prior registration through comunicacion@ciberisciii.es, from 24 October to 11 November (until full capacity)

More information

#ImproCiencia Science and theatre
Read More

Physics Prize of the Royal Spanish Society of Physics (RSEF) to Laura Lechuga

Laura M. Lechuga, Scientific Director of the Unit 4 of NANBIOSIS has won the Physics Prize of the Royal Spanish Society of Physics (RSEF) -Foundation BBVA 2016 in the form of Physics, Innovation and Technology, endowed with 8,000 euros.

Physics Awards recognize this year to researchers who have revealed the potential of the “nanoworld” to create new materials and fight disease.

The jury highlighted her “excellent track record as a scientist, technologist and innovative” in the field of biosensor devices. “Prof. Lechuga – emphasizes the jury- has managed to walk the path from idea to product with great success. Her work combines high quality science with the development of productive technologies and their transfer to the enterprise system through active participation in the creation of companies in the sector”

Physics Prize of the Royal Spanish Society of Physics (RSEF) to Laura Lechuga
Read More

Final Report of European project ITECH accepted by the Commission.

ITECH (Roadmap for Research and Innovation in Health Technologies) is a project of the 7th Framework Programme for research, technological development and dissemination in order to define a strategic plan on Health Technologies to contribute to the Common Strategic Framework for EU Horizon 2020 Research and Innovation.

Pablo Laguna, Scientific Director of Unit 27 of NANBIOSIS has participated in ITECH Committee since the inaugural meeting and kick-off of the project in September 2013. Since then, ITECH has focused on research and innovation in health technologies, medical devices and eHealth applications, it has identified barriers for ideas reaching the market and has proposed some recommendations to overcome them.

For more information:

ITECH final results
A synthesis of the ITECH Project
The final report of the project

 

Final Report of European project ITECH accepted by the Commission.
Read More